152 related articles for article (PubMed ID: 9212969)
1. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
Kagisaki K; Masai T; Kadoba K; Sawa Y; Nomura F; Fukushima N; Ichikawa H; Ohata T; Suzuki K; Taketani S; Matsuda H
Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
[TBL] [Abstract][Full Text] [Related]
2. Biocompatibility of heparin-coated extracorporeal bypass circuits: new heparin bonded bioline system.
Tayama E; Hayashida N; Akasu K; Kosuga T; Fukunaga S; Akashi H; Kawara T; Aoyagi S
Artif Organs; 2000 Aug; 24(8):618-23. PubMed ID: 10971248
[TBL] [Abstract][Full Text] [Related]
3. Biocompatibility of poly2methoxyethylacrylate coating for cardiopulmonary bypass.
Noguchi M; Eishi K; Tada S; Yamachika S; Hazama S; Izumi K; Tanigawa K
Ann Thorac Cardiovasc Surg; 2003 Feb; 9(1):22-8. PubMed ID: 12667126
[TBL] [Abstract][Full Text] [Related]
4. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
Olsson C; Siegbahn A; Henze A; Nilsson B; Venge P; Joachimsson PO; Thelin S
Scand Cardiovasc J; 2000; 34(1):33-40. PubMed ID: 10816058
[TBL] [Abstract][Full Text] [Related]
5. Comparison of three commercially available hollow fiber oxygenators: gas transfer performance and biocompatibility.
de Vroege R; Wagemakers M; te Velthuis H; Bulder E; Paulus R; Huybregts R; Wildevuur W; Eijsman L; van Oeveren W; Wildevuur C
ASAIO J; 2001; 47(1):37-44. PubMed ID: 11199313
[TBL] [Abstract][Full Text] [Related]
6. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
7. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
[TBL] [Abstract][Full Text] [Related]
8. Improvement of bypass circuit biocompatibility: comparison and combination of heparin-coated circuit and nitric oxide gas infusion.
Hayashi Y; Sawa Y; Hirata N; Nishimura M; Ueda H; Naka Y; Yamaguchi T; Ohtake S; Matsuda H
J Card Surg; 2002; 17(6):477-84. PubMed ID: 12643456
[TBL] [Abstract][Full Text] [Related]
9. Release of proinflammatory cytokines during pediatric cardiopulmonary bypass: heparin-bonded versus nonbonded oxygenators.
Ashraf S; Tian Y; Cowan D; Entress A; Martin PG; Watterson KG
Ann Thorac Surg; 1997 Dec; 64(6):1790-4. PubMed ID: 9436574
[TBL] [Abstract][Full Text] [Related]
10. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.
Steinberg BM; Grossi EA; Schwartz DS; McLoughlin DE; Aguinaga M; Bizekis C; Greenwald J; Flisser A; Spencer FC; Galloway AC
Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475
[TBL] [Abstract][Full Text] [Related]
11. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin-coated circuits and poly2methoxyethylacrylate-coated circuits).
Hazama S; Eishi K; Yamachika S; Noguchi M; Ariyoshi T; Takai H; Odate T; Matsukuma S; Onohara D; Yanatori M
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):90-6. PubMed ID: 15209550
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
[TBL] [Abstract][Full Text] [Related]
13. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
[TBL] [Abstract][Full Text] [Related]
15. Clinical evaluation of a silicone coated hollow fiber oxygenator.
Shimono T; Shomura Y; Tani K; Shimamoto A; Hioki I; Tokui T; Onoda K; Takao M; Shimpo H; Yada I
ASAIO J; 1997; 43(5):M735-9. PubMed ID: 9360143
[TBL] [Abstract][Full Text] [Related]
16. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
[TBL] [Abstract][Full Text] [Related]
17. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
[TBL] [Abstract][Full Text] [Related]
18. Heparin-coated cardiopulmonary bypass circuits in coronary bypass surgery.
Horimoto H; Kondo K; Asada K; Sasaki S
Artif Organs; 1996 Aug; 20(8):936-40. PubMed ID: 8853810
[TBL] [Abstract][Full Text] [Related]
19. Limitation of thrombin generation, platelet activation, and inflammation by elimination of cardiotomy suction in patients undergoing coronary artery bypass grafting treated with heparin-bonded circuits.
Aldea GS; Soltow LO; Chandler WL; Triggs CM; Vocelka CR; Crockett GI; Shin YT; Curtis WE; Verrier ED
J Thorac Cardiovasc Surg; 2002 Apr; 123(4):742-55. PubMed ID: 11986603
[TBL] [Abstract][Full Text] [Related]
20. Experimental studies on three types of heparin-coated cardiopulmonary bypass circuits.
Baba T; Morisita K; Sakata J; Ito T; Hachiro Y; Kazui T; Abe A; Komatu S
Artif Organs; 1997 Jul; 21(7):779-81. PubMed ID: 9212957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
